Indeed, many factors may contribute to the development of AF, such as hypertension (HTN), DM, obesity, chronic kidney disease (CKD), and HF.12 It is important to note that SGLT2 inhibitors may affect these conditions differently with various mechanisms of action, and they may be more effective in preventing AF in certain subgroups of patients. Here, SLC5A2 is linked to chronic kidney disease.